6533b86dfe1ef96bd12c9758
RESEARCH PRODUCT
Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).
Tajudheen KarattMary-ellen CvijicNeil T. BurfordJing ChenKumaragurubaran KChristopher B. CooperArvind MathurLalgudi S. HarikrishnanLauren E. KayserSukhen KarmakarNeelam SrivastavaTai W. WongYan KongGeorge L. TrainorAmrita RoyMichael A. PossDavid S. NirschlAnuradha Guptasubject
Vasoactive intestinal peptide (VIP)Settore MED/09 - Medicina InternaReceptors Vasoactive Intestinal Polypeptide Type IClinical BiochemistryVasoactive intestinal peptidePharmaceutical ScienceAntineoplastic AgentsThiophenesBiochemistrySmall Molecule LibrariesStructure-Activity RelationshipCell Line TumorDrug DiscoveryStructure–activity relationshipHumansReceptorMolecular BiologyChemistryVasoactive intestinal peptide receptorOrganic ChemistryBiphenyl CompoundsSmall Molecule LibrariesSmall moleculeHigh-Throughput Screening AssaysBiochemistryCell cultureVasoactive intestinal peptide receptor (VIPR)Molecular MedicineDrug Screening Assays AntitumorVIPR1description
Identification, synthesis and structure-activity relationship of small-molecule VIPR1 antagonists encompassing two chemical series are described.
year | journal | country | edition | language |
---|---|---|---|---|
2012-03-01 | Bioorganicmedicinal chemistry letters |